RHYTHM PHARMACEUTICALS, INC. RYTM
RHYTHM PHARMACEUTICALS, INC. statistics & valuation
Market cap$7.5B
P / S39.7×
P / B54.2×
Net margin-103.6%
Return on equity-141.3%
FCF margin-61.5%
Net debt$46.6M
Enterprise value USD$7.6B
Earnings yield EBIT/EV-2.5%
Return on capital-51.3%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | -101.2% | -204.0% | -238.1% | -757.9% | -5391.9% | — | — | — | — | — |
| Net margin | -103.6% | -200.3% | -238.5% | -766.2% | -2207.1% | — | — | — | — | — |
| FCF margin | -61.5% | -87.5% | -175.9% | -734.9% | -4642.9% | — | — | — | — | — |
| Return on assets | -40.9% | -66.4% | -55.5% | -47.4% | -21.1% | -71.6% | -45.6% | -28.5% | -22.2% | — |
| Return on equity | -141.3% | -1199.3% | -108.8% | -68.5% | -24.5% | -80.5% | -50.1% | -30.1% | -23.3% | — |
| Debt / equity | 0.73× | 4.98× | 0.63× | — | — | — | — | — | — | — |
| Current ratio | 4.41 | 3.24 | 5.58 | 8.90 | 7.10 | 10.10 | 12.38 | 19.05 | 22.42 | 2.36 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.